Uslin (recombinant human insulin biosimilar)
/ United Laboratories
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
May 28, 2026
Comparative Clinical Trial of Pharmacokinetics and Pharmacodynamics of Human Insulin Injection
(clinicaltrials.gov)
- P1 | N=32 | Completed | Sponsor: Zhuhai United Laboratories Co., Ltd.
New P1 trial
1 to 1
Of
1
Go to page
1